SMANTIS and glioblastoma: Since SMANTIS is a disease-relevant lncRNA as shown previously in endothelial cells isolated from glioblastoma and pulmonary arterial hypertension5,6, the clinical relevance of SMANTIS in blood cells was evaluated in a transcriptomic data set of an AML patient (>100) cohort16.